Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review.

[1]  Julie W. Doberne,et al.  The future of heart procurement with donation after circulatory death: Current practice and opportunities for advancement. , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  S. Tohyama,et al.  Protocol for enhanced proliferation of human pluripotent stem cells in tryptophan-fortified media , 2022, STAR protocols.

[3]  K. Fukuda,et al.  The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells , 2021, Frontiers in Cardiovascular Medicine.

[4]  K. Fukuda,et al.  Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy. , 2021, Journal of molecular and cellular cardiology.

[5]  T. Imamura,et al.  Consensus Report on Destination Therapy in Japan　- From the DT Committee of the Council for Clinical Use of Ventricular Assist Device Related Academic Societies. , 2021, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Y. Tabata,et al.  Intramyocardial Transplantation of Human iPS Cell–Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals , 2021, JACC. Basic to translational science.

[7]  Lauren E. Neidig,et al.  Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes , 2021, bioRxiv.

[8]  K. Fukuda,et al.  Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes , 2021, Inflammation and regeneration.

[9]  K. Fukuda,et al.  Tryptophan Metabolism Regulates Proliferative Capacity of Human Pluripotent Stem Cells , 2021, iScience.

[10]  M. Ko,et al.  Fatty Acid Synthesis Is Indispensable for Survival of Human Pluripotent Stem Cells , 2020, iScience.

[11]  P. Ponikowski,et al.  Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. , 2020, The New England journal of medicine.

[12]  P. Ponikowski,et al.  Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. , 2020, The New England journal of medicine.

[13]  Jun Zhu,et al.  Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study , 2020, The Lancet.

[14]  S. Marchianò,et al.  Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine , 2020, Nature Reviews Cardiology.

[15]  K. Fukuda,et al.  Toward the realization of cardiac regenerative medicine using pluripotent stem cells , 2020, Inflammation and Regeneration.

[16]  Mark M. Davis,et al.  Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients , 2019, Nature Biotechnology.

[17]  J. Rogers,et al.  Increasing the United States heart transplant donor pool with donation after circulatory death. , 2020, The Journal of thoracic and cardiovascular surgery.

[18]  J. Molkentin,et al.  An acute immune response underlies the benefit of cardiac stem cell therapy , 2019, Nature.

[19]  Akshay S. Desai,et al.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. , 2019, The New England journal of medicine.

[20]  Akshay S. Desai,et al.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. , 2019, The New England journal of medicine.

[21]  T. Watabe,et al.  MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets to Improve Cardiac Function in A Primate Ischemic Cardiomyopathy Model. , 2019, Transplantation.

[22]  S. Tohyama,et al.  Concise Review: Genetic and Epigenetic Regulation of Cardiac Differentiation from Human Pluripotent Stem Cells , 2019, Stem cells.

[23]  G. Wright,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias , 2019, Stem cell reports.

[24]  Chad A. Cowan,et al.  Generation of hypoimmunogenic human pluripotent stem cells , 2019, Proceedings of the National Academy of Sciences.

[25]  S. Senju,et al.  Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3. , 2019, Biochemical and biophysical research communications.

[26]  P. Gee,et al.  Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility. , 2019, Cell stem cell.

[27]  R. Hobbs,et al.  Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study , 2019, BMJ.

[28]  Y. Tabata,et al.  Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  R. Radovancevic,et al.  Obesity Is Associated with Driveline Infection of Left Ventricular Assist Devices. , 2019, ASAIO journal.

[30]  Lil Pabon,et al.  Human ESC-Derived Cardiomyocytes Restore Function in Infarcted Hearts of Non-Human Primates , 2018, Nature Biotechnology.

[31]  Harry Hemingway,et al.  Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals , 2017, The Lancet.

[32]  Keiichi Fukuda,et al.  Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes , 2017, Stem cell reports.

[33]  Karin Hayashi,et al.  Efficient, Selective Removal of Human Pluripotent Stem Cells via Ecto-Alkaline Phosphatase-Mediated Aggregation of Synthetic Peptides. , 2017, Cell chemical biology.

[34]  D. Clegg,et al.  HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells , 2017, Nature Biotechnology.

[35]  Lil Pabon,et al.  In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts , 2017, Stem cell reports.

[36]  M. Ohkura,et al.  Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts , 2016, Nature.

[37]  D. Mancini,et al.  The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices. , 2016, JACC. Heart failure.

[38]  Shinya Yamanaka,et al.  MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells , 2016, Scientific Reports.

[39]  M. Suematsu,et al.  Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells. , 2016, Cell metabolism.

[40]  Robert Zweigerdt,et al.  Large-scale production of human pluripotent stem cell derived cardiomyocytes. , 2016, Advanced drug delivery reviews.

[41]  Y. Quan,et al.  Targeted Disruption of the β2‐Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells , 2015, Stem cells translational medicine.

[42]  M. Garry,et al.  Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies. , 2015, Journal of cardiac failure.

[43]  H. Shimokawa,et al.  Heart failure as a general pandemic in Asia , 2015, European journal of heart failure.

[44]  Mohsin Khan,et al.  Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. , 2015, Circulation research.

[45]  J. Hirabayashi,et al.  Elimination of Tumorigenic Human Pluripotent Stem Cells by a Recombinant Lectin-Toxin Fusion Protein , 2015, Stem cell reports.

[46]  E. Finch,et al.  MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. , 2015, Circulation research.

[47]  Ying Ge,et al.  Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. , 2014, Cell stem cell.

[48]  S. Yuasa,et al.  A Massive Suspension Culture System With Metabolic Purification for Human Pluripotent Stem Cell‐Derived Cardiomyocytes , 2014, Stem cells translational medicine.

[49]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[50]  Praveen Shukla,et al.  Chemically defined generation of human cardiomyocytes , 2014, Nature Methods.

[51]  Charles E. Murry,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.

[52]  H. Onoe,et al.  Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate , 2013, Stem cell reports.

[53]  Lei Yang,et al.  Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells , 2013, Nature Communications.

[54]  Pei-Rong Wang,et al.  HLA engineering of human pluripotent stem cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[55]  Lior Gepstein,et al.  Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. , 2013, European heart journal.

[56]  M. Suematsu,et al.  Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.

[57]  Sean P. Palecek,et al.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.

[58]  K. Fukuda,et al.  Myocardial cell sheet therapy and cardiac function. , 2012, American journal of physiology. Heart and circulatory physiology.

[59]  K. Fukuda,et al.  The effectiveness of rigid pericardial endoscopy for minimally invasive minor surgeries: cell transplantation, epicardial pacemaker lead implantation, and epicardial ablation , 2012, Journal of Cardiothoracic Surgery.

[60]  P. Burridge,et al.  Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. , 2012, Journal of molecular and cellular cardiology.

[61]  Atsushi Izawa,et al.  hESC-Derived Cardiomyocytes Electrically Couple and Suppress Arrhythmias in Injured Hearts , 2012, Nature.

[62]  Teruo Okano,et al.  Pluripotent Stem Cell‐Engineered Cell Sheets Reassembled with Defined Cardiovascular Populations Ameliorate Reduction in Infarct Heart Function Through Cardiomyocyte‐Mediated Neovascularization , 2012, Stem cells.

[63]  Gordon Keller,et al.  SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells , 2011, Nature Biotechnology.

[64]  D. Sahoo,et al.  An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.

[65]  Michael Böhm,et al.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.

[66]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[67]  Alessandro Giacomello,et al.  Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice , 2010, Circulation research.

[68]  E. Sasaki,et al.  Nongenetic method for purifying stem cell–derived cardiomyocytes , 2010, Nature Methods.

[69]  M. Murata,et al.  Omentopexy enhances graft function in myocardial cell sheet transplantation. , 2009, Biochemical and biophysical research communications.

[70]  Wuqiang Zhu,et al.  Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 Expression , 2009, Circulation research.

[71]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[72]  C. Fong,et al.  Separation of SSEA-4 and TRA-1–60 Labelled Undifferentiated Human Embryonic Stem Cells from A Heterogeneous Cell Population Using Magnetic-Activated Cell Sorting (MACS) and Fluorescence-Activated Cell Sorting (FACS) , 2009, Stem Cell Reviews and Reports.

[73]  H. Haider,et al.  IGF-1–Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell Mobilization via Paracrine Activation of SDF-1α/CXCR4 Signaling to Promote Myocardial Repair , 2008, Circulation research.

[74]  S. Yuasa,et al.  Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era , 2008, Expert review of cardiovascular therapy.

[75]  O. Alfieri,et al.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.

[76]  Masahiro Ito,et al.  Impending epidemic: future projection of heart failure in Japan to the year 2055. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[77]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[78]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[79]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[80]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  Shinsuke Yuasa,et al.  Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets. , 2005, Cardiovascular research.

[82]  M. Suematsu,et al.  Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. , 2005, Cardiovascular research.

[83]  J. M. Boss,et al.  The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. , 1999, American journal of human genetics.

[84]  G Olivetti,et al.  Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. , 1990, Circulation research.

[85]  H. Gold,et al.  The relationship of myocardial infarct size and prognosis. , 1976, Circulation.